Abstract

Background: Insulin resistance is a major risk factor in the development of cardiovascular diseases and type 2 diabetes mellitus. Some studies concluded that serum lipoproteins levels and hence lipoprotein ratios were altered in patients with insulin resistance. Objective: To identify the possibility of using lipoprotein ratios as markers for insulin resistance. Methods: A cross sectional study conducted in Baghdad (Medical City) and in Maysan (Al Shaheed Al Sadir Teaching Hospital) from February to December 2020. Eighty-three male and 51 female in Coronary Care Unit and Internal Medicine Wards patients were selected in the study group. Results: Lipoprotein ratios were significantly higher in individuals with homeostatic model assessment for insulin resistance (HOMA-IR) ≥2.5 as compared to subjects with HOMA-IR <2.5. There was a statistically significant association between lipoprotein ratios and insulin resistance when HOMA-IR ≥2.5 (P less than 0.05). Fasting insulin correlated significantly with lipoprotein ratios. Conclusion: Serum lipoprotein ratios and the best one is triglyceride/high density lipoprotein cholesterol could be used as markers for insulin resistance. Keywords: Lipoprotein ratios, insulin resistance, diabetes Citation: Issa EF, Rasheed MK. Serum lipoprotein ratios as markers for insulin resistance among non-diabetic acute coronary syndrome patients with impaired fasting glucose. Iraqi JMS. 2022; 20(2): 239-244. doi: 10.22578/IJMS.20.2.11

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.